Frontlight ResearchEarly access
Trial site
Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto
- 13running trials
- 1closed trial
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Heart failure3 trials
- Lung cancer3 trials
- Lupus (SLE)3 trials
- Obesity2 trials
- Acute myeloid leukaemia1 trial
- Chronic kidney disease1 trial
- Colorectal cancer1 trial
- Gastric and oesophageal cancer1 trial
- Type 1 diabetes1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 311 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Recruiting7 trials
- Active, not recruiting3 trials
- Not yet recruiting2 trials
- Completed1 trial
- Enrolling by invitation1 trial
- Lead sponsor
- Daiichi Sankyo4 trials
- Novo Nordisk A/S4 trials
- Biogen2 trials
- Boehringer Ingelheim1 trial
- Genentech, Inc.1 trial
- and 2 more
Running trials
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Active, not recruiting
Recruiting
Enrolling by invitation
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure2 recruiting
- Lung cancer2 recruiting
- Lupus (SLE)2 recruiting
- Obesity2 recruiting
- Colorectal cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Type 1 diabetes1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026